Targeted Therapeutics

Slides:



Advertisements
Similar presentations
Cancer Metabolism Cell Volume 148, Issue 3, (February 2012) DOI: /j.cell Copyright © 2012 Terms and Conditions Terms and Conditions.
Advertisements

The Good Fat Cell Volume 147, Issue 7, (December 2011) DOI: /j.cell Copyright © 2011 Terms and Conditions Terms and Conditions.
Phase I Study of H5.020CMV.PDGF-β to Treat Venous Leg Ulcer Disease
Volume 14, Issue 3, Pages (September 2006)
The Coming Peptide Tidal Wave
Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human Cancers  Melinda Mata, Stephen.
Volume 2, Issue 1, Pages (July 2000)
Scratching the Surface of Immunotherapeutic Targets in Neuroblastoma
Volume 137, Issue 2, Pages e2 (August 2009)
Will Engineered T Cells Expressing CD20 scFv Eradicate Melanoma?
Therapeutic Suppression of miR-4261 Attenuates Colorectal Cancer by Targeting MCC  Guanming Jiao, Qi Huang, Muren Hu, Xuchun Liang, Fuchen Li, Chunling.
Volume 16, Issue 8, Pages (August 2008)
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Waging War on Cancer with the Sword of Immunity
Organ Regeneration Cell Volume 146, Issue 1, (July 2011)
Scratching the Surface of Immunotherapeutic Targets in Neuroblastoma
Volume 25, Issue 12, Pages (December 2017)
Volume 9, Issue 3, Pages (March 2004)
Volume 7, Issue 3, Pages (March 2003)
Volume 10, Issue 4, Pages (October 2004)
Volume 22, Issue 3, Pages (March 2014)
Cancer and the Immune System
In This Issue Cell Volume 158, Issue 5, (August 2014)
Molecular Therapy - Oncolytics
Phase I Study of H5.020CMV.PDGF-β to Treat Venous Leg Ulcer Disease
Liposome Enhances CRAd Therapy
Molecular Therapy - Methods & Clinical Development
T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma
Volume 12, Issue 1, Pages (July 2007)
A Theranostic “SMART” Aptamer for Targeted Therapy of Prostate Cancer
Volume 10, Issue 2, Pages (August 2004)
Volume 2, Issue 1, Pages (July 2000)
Volume 22, Issue 10, Pages (October 2014)
Volume 152, Issue 1, (January 2013)
The Other Face of Chimeric Antigen Receptors
Volume 23, Issue 4, Pages (April 2015)
Volume 16, Issue 8, Pages (August 2008)
Volume 18, Issue 11, Pages (November 2010)
Volume 18, Issue 3, Pages (March 2010)
Efficient Gene Expression in Skin Wound Sites Following Local Plasmid Injection  Martin Meuli, Yong Liu, Denny Liggitt, Mohammed Kashani-Sabet, Sharon.
Research Techniques Made Simple: CAR T-Cell Therapy
Volume 15, Issue 5, Pages (May 2007)
Volume 130, Issue 6, (September 2007)
Volume 18, Issue 9, Pages (September 2010)
Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen- Specific Regulatory T Cells  Dan Blat, Ehud Zigmond, Zoya Alteber,
Molecular Therapy - Nucleic Acids
Volume 9, Issue 6, Pages (June 2004)
Volume 9, Issue 4, Pages (November 2014)
Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models  Fabrice Le Boeuf, Simon Gebremeskel,
Volume 143, Issue 6, (December 2010)
Volume 16, Issue 6, Pages (June 2008)
Volume 10, Issue 4, Pages (October 2004)
Volume 22, Issue 1, Pages (January 2014)
Volume 8, Issue 16, Pages R551-R553 (July 1998)
Heather M. Ames, Christopher K. Bichakjian, Grace Y. Liu, Katherine I
Volume 19, Issue 6, Pages (June 2011)
Volume 18, Issue 5, Pages (May 2010)
Volume 19, Issue 7, Pages (July 2011)
Volume 10, Issue 2, Pages (August 2004)
Molecular Therapy  Volume 21, Pages S247-S248 (May 2013)
Sindbis Viral Vectors Transiently Deliver Tumor-associated Antigens to Lymph Nodes and Elicit Diversified Antitumor CD8+ T-cell Immunity  Tomer Granot,
Volume 4, Issue 4, Pages (October 2001)
The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI  Feng Xing, Shuo Wang, Jianhong Zhou  Molecular.
Volume 163, Issue 4, (November 2015)
Volume 163, Issue 2, (October 2015)
Fig. 1 Engineered T cells: design of TCR versus CAR T cells.
CAR T cell immunotherapy for human cancer
Volume 134, Issue 6, (September 2008)
In This Issue Cell Volume 145, Issue 3, (April 2011)
Volume 148, Issue 1, (January 2012)
Presentation transcript:

Targeted Therapeutics   Cell  Volume 147, Issue 2, (October 2011) DOI: 10.1016/j.cell.2011.09.043 Copyright © 2011 Terms and Conditions

Bispecific T cells are created by the introduction of genes that encode the heterodimeric T cell receptor (top) or chimeric antigen receptors (CARs) that target surface antigens in an MHC-independent fashion (bottom) (LAT, linker for activation of T cells; ScFv, single-chain variable fragment; ZAP70, zeta chain-associated protein kinase 70 kDa). Image courtesy of C. June. Cell 2011 147, DOI: (10.1016/j.cell.2011.09.043) Copyright © 2011 Terms and Conditions

Luciferase imaging of mice after tail vein injection with DNA plasmid liposomes demonstrates that the engineered vector (VISA-claudin4-Luc) is selectively expressed in tumor, but not in normal, tissues, whereas a nonspecific vector (CMV-Luc) was primarily expressed in normal lung, the first targeting tissue after tail vein injection. Cell 2011 147, DOI: (10.1016/j.cell.2011.09.043) Copyright © 2011 Terms and Conditions

Representative echocardiographic images of a control and S100A1-treated pig heart demonstrate that S100A1 effectively prevents and reverses left ventricular dysfunction 3 months after cardiac-targeted intravenous gene therapy. Image courtesy of Patrick Most, Sven Pleger, and Christophe Weber, Centre for Molecular and Translational Cardiology, Department of Medicine III, Heidelberg University, Germany. Cell 2011 147, DOI: (10.1016/j.cell.2011.09.043) Copyright © 2011 Terms and Conditions

Immunohistochemical staining for vaccinia in biopsy of patient with metastatic colorectal cancer 10 days following viral (JX-594) infusion demonstrates selective infection of tumor cells. Image courtesy of Caroline Breitbach and David Kirn. Cell 2011 147, DOI: (10.1016/j.cell.2011.09.043) Copyright © 2011 Terms and Conditions